Fortitude Family Office, LLC Sc Pharmaceuticals Inc. Transaction History
Fortitude Family Office, LLC
- $372 Billion
- Q3 2025
A detailed history of Fortitude Family Office, LLC transactions in Sc Pharmaceuticals Inc. stock. As of the latest transaction made, Fortitude Family Office, LLC holds 613 shares of SCPH stock, worth $3,475. This represents 0.0% of its overall portfolio holdings.
Number of Shares
613
Previous 613
-0.0%
Holding current value
$3,475
Previous $2.34 Million
48.8%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding SCPH
# of Institutions
117Shares Held
38.3MCall Options Held
835KPut Options Held
173K-
Orbimed Advisors LLC San Diego, CA6.06MShares$34.4 Million1.17% of portfolio
-
Rubric Capital Management LP New York, NY5.1MShares$28.9 Million0.47% of portfolio
-
Weiss Asset Management LP Boston, MA2.88MShares$16.3 Million0.31% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.18MShares$12.3 Million0.0% of portfolio
-
King Luther Capital Management Corp Fort Worth, TX2.13MShares$12.1 Million0.05% of portfolio
About scPharmaceuticals Inc.
- Ticker SCPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,402,100
- Market Cap $155M
- Description
- scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion in patients with heart failure. Its product p...